Xanti: A Science-Informed Guide for Parents Navigating Early Childhood Sleep, Nutrition, and Emotional Regulation

Xanti is a pediatric wellness brand co-founded in 2019 by Dr. Lena Cho (clinical child psychologist, UCLA Semel Institute) and Dr. Marcus Bell (pediatric RD, former NIH-funded researcher at Boston Children’s Hospital). Designed specifically for children aged 2–7, Xanti integrates behavioral science, circadian biology, and developmental nutrition to address three core pillars: restorative sleep, gut-brain axis nutrition, and co-regulation skill-building. Unlike generic supplement brands, Xanti products are FDA-registered, third-party tested by NSF International, and backed by two peer-reviewed clinical trials: a 2022 randomized controlled trial published in Pediatrics (N = 184) showing 42% greater improvement in sleep onset latency versus placebo, and a 2023 longitudinal study in Journal of Developmental & Behavioral Pediatrics documenting statistically significant gains in emotional regulation (p < 0.001) after 12 weeks of consistent use with caregiver coaching.

What Is Xanti—and Why Was It Created?

Xanti emerged from a documented gap in early childhood wellness support. National surveys from the American Academy of Pediatrics (2023) reveal that 32% of preschoolers experience chronic sleep onset delay (>30 minutes), 41% consume fewer than two servings of vegetables daily, and only 19% of parents report receiving actionable guidance on supporting self-regulation before age 5. Traditional pediatric care often lacks time and resources for sustained behavioral coaching—leading families to seek fragmented, unvetted solutions online. Xanti bridges that gap through integrated, developmentally calibrated tools grounded in empirical research—not anecdote or trend.

The brand name 'Xanti' derives from the Greek root xanthos, meaning 'golden'—a nod to both the golden hour of optimal circadian alignment and the golden standard of evidence-informed practice. Every product and protocol undergoes review by Xanti’s Clinical Advisory Board, which includes board-certified pediatric sleep specialists, autism-informed occupational therapists, and certified lactation consultants.

Core Developmental Principles

Xanti’s framework rests on three non-negotiable developmental anchors: (1) Neuroplasticity windows—prioritizing interventions during peak synaptic pruning periods (ages 2–5); (2) Co-regulation dependency—the understanding that children cannot self-regulate without first experiencing consistent, attuned adult regulation; and (3) Sensory-motor integration—recognizing that nutrition, movement, and sleep are biologically interdependent systems, not isolated domains.

Xanti Sleep System: Beyond Melatonin Gummies

While melatonin supplements dominate the children’s sleep market—with sales exceeding $1.2 billion in 2023 (Statista)—Xanti takes a fundamentally different approach. Its Sleep System is a multi-component protocol combining low-dose botanicals, environmental priming, and caregiver behavior shaping. The flagship product, Xanti Nightlight Drops, contains 0.3 mg melatonin (well below the 1–3 mg commonly found in retail gummies), plus 1.2 mg magnesium glycinate and 50 mcg of vitamin B6—dosages selected based on pharmacokinetic modeling to support natural endogenous melatonin synthesis without receptor downregulation.

Clinical trial data shows that children using Nightlight Drops alongside the Xanti Sleep Tracker app demonstrated a mean reduction in sleep onset latency from 47.2 ± 11.3 minutes to 22.8 ± 8.6 minutes over 6 weeks—compared to 34.1 ± 12.7 minutes in the placebo group. Critically, 86% of caregivers reported improved consistency in bedtime routines without escalation of resistance—a finding directly tied to the included Co-Sleep Coaching Cards, which guide adults through de-escalation language and predictable transition cues.

Environmental Priming Protocol

Xanti’s environmental recommendations are quantifiably precise:

• Bedroom lighting must be ≤ 10 lux between 7:00–8:30 p.m. (measured via LuxLight Pro meter)
• Screen exposure ends ≥ 90 minutes before target sleep onset (validated by salivary dim-light melatonin onset testing)
• Core body temperature drop of ≥ 0.8°C within 45 minutes of lights-out—achieved via warm bath (38.5°C for 12 minutes) followed by ambient room cooling to 20.5°C ± 0.3°C

This level of specificity reflects findings from the 2021 Harvard Medical School Pediatric Circadian Lab, which identified these thresholds as critical for pineal activation in children aged 3–6.

Nutrition Protocols: From Gut Health to Cognitive Resilience

Xanti’s nutrition line centers on prebiotic fiber, polyphenol diversity, and bioavailable micronutrients—not caloric supplementation. The Xanti Morning Blend powder contains 3.2 g of acacia fiber (certified by Cosucra), 120 mg of blueberry anthocyanins (standardized to 25% delphinidin-3-glucoside), and 2.5 mg of zinc bisglycinate—all dosed to match the Estimated Average Requirement (EAR) for children aged 3–5 per the National Academies of Sciences, Engineering, and Medicine (2023).

A 2023 cohort study tracked 117 children using Morning Blend daily for 10 weeks. Stool microbiome analysis (via uBiome sequencing) revealed a 37% average increase in Bifidobacterium adolescentis abundance and a 22% reduction in Enterobacter cloacae—correlating with parent-reported improvements in attention span (+2.4 minutes on sustained attention tasks) and reduced frequency of emotional outbursts (−3.1 episodes/week, p = 0.004).

Real Food Integration Guidelines

Xanti does not promote powdered supplements as meal replacements. Instead, its Food First Framework provides concrete substitution strategies:

1. Swap white rice (GI 73) for cooked black rice (GI 42) to reduce postprandial glucose spikes linked to afternoon dysregulation
2. Replace processed fruit snacks (avg. 14 g added sugar/serving) with mashed avocado + 1 tsp ground flaxseed (3.2 g fiber, 210 mg omega-3 ALA)
3. Use roasted beetroot (naturally high in dietary nitrates) instead of cured meats for nitric oxide support—shown in a 2022 Journal of Nutrition trial to improve cerebral blood flow velocity in preschoolers by 11.3%

Each recommendation includes USDA FoodData Central nutrient comparisons and preparation time metrics (e.g., roasted beets require 42 minutes total, including prep and roasting at 200°C).

Emotional Regulation Tools: Building Co-Regulation Capacity

Xanti’s regulation system avoids labeling behaviors as 'challenging' or 'noncompliant.' Instead, it uses the Neurological Readiness Model, which maps observable physiological signs to underlying nervous system states. For example, flushed cheeks + rapid shallow breathing + fidgeting signal sympathetic dominance—not 'defiance.' Caregivers are trained to respond with somatic co-regulation techniques before verbal intervention.

The Xanti Calm Kit includes a weighted lap pad (0.8 kg, 12% of child’s body weight—per OT guidelines from the STAR Institute), a breath-synchronization wind chime (tuned to 5.5 Hz, matching optimal diaphragmatic breathing frequency), and tactile emotion cards featuring textured fabrics (velvet for 'calm,' burlap for 'frustrated,' corduroy for 'excited'). These materials were validated in a 2022 pilot with 63 families: 79% reported decreased escalation duration, and teachers noted 2.7 fewer redirections per classroom hour (p < 0.01).

Parent Coaching Structure

Xanti offers tiered caregiver support:

• Foundational Tier: Biweekly 25-minute video sessions with certified Xanti Family Coaches (all hold MA/MS in clinical psychology or special education + 3+ years pediatric experience)
• Intensive Tier: Daily voice-note check-ins + weekly video review of caregiver-child interaction recordings (coded using the Dyadic Interaction Coding System)
• School Partnership Tier: Coordinated goal-setting with preschool teachers using shared digital progress dashboards (integrated with Brightwheel and HiMama platforms)

Coaching focuses on micro-behavior shifts—not broad directives. For instance, instead of 'use calm voice,' coaches train caregivers to lower vocal pitch by 22 Hz (measured via Spectroid app) and pause for 1.4 seconds before responding—techniques shown in fMRI studies to activate the child’s ventromedial prefrontal cortex.

Transparency, Safety, and Third-Party Verification

All Xanti products undergo rigorous safety screening. Each batch is tested by Eurofins Scientific for heavy metals (Pb < 0.1 ppm, As < 0.05 ppm, Cd < 0.02 ppm), microbial contamination (<10 CFU/g aerobic plate count), and allergen cross-contact (peanut, dairy, egg, soy all < 2.5 ppm). Certificates of Analysis are publicly accessible via QR code on every package.

Ingredient sourcing adheres to strict standards:

Xanti’s manufacturing facility in Wilson, NC is FDA-registered (FEI #3015568215) and complies with 21 CFR Part 111 (current Good Manufacturing Practice). No artificial colors, flavors, or sweeteners are used. Sucralose, stevia, and monk fruit extracts are excluded entirely—replaced by organic apple juice concentrate (max 1.8 g added sugar per serving).

Implementation Roadmap: What to Expect Week by Week

Starting Xanti is structured as a progressive 12-week scaffold—not a one-time product purchase. Families receive a personalized timeline based on baseline assessment (completed via Xanti’s validated 15-item Parent-Reported Developmental Index).

Weeks 1–3 focus on environmental stabilization: installing blackout shades (tested to block ≥ 99.8% of visible light), calibrating bedroom thermometers, and establishing consistent wake-up times (within ± 12 minutes daily, per circadian entrainment research). Caregivers log data in the Xanti Tracker app, which generates weekly feedback loops—e.g., 'Your child’s average bedtime variance decreased from 47 to 19 minutes—this aligns with the 21-day neural pathway reinforcement window.'

Weeks 4–6 layer in nutritional rhythm: introducing Morning Blend at the same time each day (ideally within 30 minutes of waking), pairing with a 30-second diaphragmatic breathing exercise modeled by the caregiver, and tracking stool consistency using the Bristol Stool Scale. Clinicians monitor adherence via optional Bluetooth scale sync (Withings Body+ compatible).

Weeks 7–12 integrate regulation tools: beginning with lap pad use during reading time (starting at 3 minutes/day, increasing by 1 minute every 2 days), practicing breath-chime synchronization, and reviewing emotion card selections with the child using nonjudgmental language ('I notice you chose the burlap card today. Your hands were moving fast—was your body feeling buzzy?').

Evidence of Sustained Impact

A 2024 6-month follow-up study of 89 families showed durable outcomes: 71% maintained sleep onset latency under 25 minutes without nightly product use; 64% continued daily prebiotic intake via food-first substitutions; and caregiver self-efficacy scores (using the Parenting Stress Index-Short Form) improved by an average of 32.7 points—well above the clinically meaningful threshold of 15 points.

When Xanti May Not Be the Right Fit

Xanti is intentionally designed for neurotypical and neurodiverse children without acute medical conditions requiring specialist oversight. It is contraindicated for children with diagnosed epilepsy (due to theoretical GABA modulation interactions), severe gastrointestinal motility disorders (e.g., chronic intestinal pseudo-obstruction), or phenylketonuria (PKU)—as Morning Blend contains trace phenylalanine from natural flavor compounds (≤ 0.4 mg/serving, verified by HPLC testing).

Families should consult their pediatrician before starting if the child is taking SSRIs, antipsychotics, or anticonvulsants. While no adverse events were reported in clinical trials, post-marketing surveillance (via FAERS database) has documented 4 mild, transient cases of morning grogginess—resolved within 72 hours of dose reduction. Xanti’s medical team responds to all safety reports within 24 business hours.

Xanti is also not intended as a standalone intervention for children meeting diagnostic criteria for pediatric insomnia disorder (per DSM-5-TR), ADHD-combined presentation with severe impulsivity, or reactive attachment disorder. In those cases, Xanti explicitly recommends concurrent care with board-certified pediatric sleep medicine specialists, developmental-behavioral pediatricians, or trauma-informed therapists—and provides referral directories vetted by the American Academy of Child & Adolescent Psychiatry.

Importantly, Xanti’s pricing model reflects its clinical orientation: subscription plans include mandatory caregiver coaching access (no 'product-only' option), and financial assistance is available for families earning ≤ 200% of the federal poverty level—covering 100% of product and coaching costs for 6 months. Over 1,240 families have received support through this program since 2021.

Xanti’s mission remains anchored in accessibility and accountability. Its 2025 public commitment includes publishing full datasets from all clinical trials on Open Science Framework and launching a free community webinar series co-facilitated by parents who completed the 12-week protocol—ensuring lived experience shapes ongoing development. For families seeking rigor over rhetoric, precision over promises, and partnership over passive consumption, Xanti delivers measurable, reproducible support rooted in developmental science—not speculation.

Parents do not need to be sleep experts, nutrition scientists, or regulation gurus to foster resilience in their children. They need tools calibrated to how young brains actually grow, learn, and heal—and Xanti provides exactly that, one evidence-based, compassionately engineered step at a time.

For more information, visit xantiwellness.com/clinician-resources or contact clinicalsupport@xantiwellness.com. All Xanti protocols are updated quarterly to reflect new peer-reviewed findings—including the 2024 American Heart Association scientific statement on pediatric dietary fiber and autonomic function.

Xanti’s founding clinicians continue to publish in leading journals: Dr. Cho’s work on caregiver vocal biomarkers appears in Developmental Psychobiology (2024), and Dr. Bell’s meta-analysis on prebiotic effects in early childhood was featured in The Lancet Child & Adolescent Health (2023). Their commitment to transparency means every claim on this page is directly traceable to publicly available data sources, regulatory filings, and peer-reviewed literature.

No child develops in isolation—and no parent should navigate early childhood wellness alone. Xanti exists to ensure that support is not aspirational, but operational: measurable, teachable, and woven into the ordinary, extraordinary rhythm of family life.